Policy on Advanced Therapy Medicinal Products (ATMP) Regulation and the Quality and Safety Regulations
Joint statement from the Human Tissue Authority (HTA) and the Medicines and Healthcare products Regulatory Agency (MHRA).
More information about the HTA removal licence including how to apply
Guide to Quality and Safety Assurance for Human Tissues and Cells for Patient Treatment
HTA and MHRA Policy on the Regulation of Blood as a Starting Material for ATMP Manufacture
This page covers the skills and knowledge which Sands' believes is necessary for those seeking consent/authorisation for a hospital post mortem examination of a baby. Sands is the stillbirth and neonatal death charity.
Information to help midwives, maternity units and other cord blood procurers understand the legal requirements for cord blood collection
Information for Independent Assessors and Living Donor Coordinators
Traceability of stem cells distributed by Advanced Cell Therapeutics / Biomark / CellTech / BioCells
The HTA has published its revised guidance on the public display of human bodies, body parts and tissue following an extensive consultation.
Which research activities the HTA requlates and how consent should be obtained to use human tissue for research